Compile Data Set for Download or QSAR
Report error Found 151 Enz. Inhib. hit(s) with all data for entry = 13144
TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762753(US20250248973, Compound 9)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762752(US20250248973, Compound 6)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762754(US20250248973, Compound 11)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762753(US20250248973, Compound 9)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762755(US20250248973, Compound 13)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762754(US20250248973, Compound 11)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762802(US20250248973, Compound 151)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762749(US20250248973, Compound 1)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762798(US20250248973, Compound 143)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762749(US20250248973, Compound 1)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762751(US20250248973, Compound 5)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762798(US20250248973, Compound 143)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762808(US20250248973, Compound 163)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762759(US20250248973, Compound 21)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762761(US20250248973, Compound 26)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762809(US20250248973, Compound 165)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762762(US20250248973, Compound 27)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762810(US20250248973, Compound 167)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762763(US20250248973, Compound 29)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762811(US20250248973, Compound 169)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762762(US20250248973, Compound 27)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762810(US20250248973, Compound 167)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762756(US20250248973, Compound 14)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762804(US20250248973, Compound 155)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762755(US20250248973, Compound 13)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762803(US20250248973, Compound 153)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762757(US20250248973, Compound 17)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762805(US20250248973, Compound 157)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762756(US20250248973, Compound 14)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762804(US20250248973, Compound 155)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762758(US20250248973, Compound 18)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762806(US20250248973, Compound 159)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762759(US20250248973, Compound 21)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762806(US20250248973, Compound 159)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762768(US20250248973, Compound 45)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762773(US20250248973, Compound 54)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762816(US20250248973, Compound 191)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762767(US20250248973, Compound 43)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762769(US20250248973, Compound 47)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762768(US20250248973, Compound 45)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762816(US20250248973, Compound 191)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762770(US20250248973, Compound 48)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762769(US20250248973, Compound 47)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762817(US20250248973, Compound 226)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762819(US20250248973, Compound 228)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762770(US20250248973, Compound 48)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762764(US20250248973, Compound 31)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetCB1 cannabinoid receptor-interacting protein 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762772(US20250248973, Compound 53)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762763(US20250248973, Compound 29)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

TargetIsoform 3 of Cannabinoid receptor 1(Human)
Corbus Pharmaceuticals

US Patent
LigandPNGBDBM762811(US20250248973, Compound 169)
Affinity DataIC50: 100nMAssay Description:hCB1/hCB1 b Gai Cyclic AMP (cAMP) Assays: Cells were seeded in a 384-well plate at an appropriate density from frozen cells. The cAMP assays were per...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/21/2025
Entry Details
US Patent

Displayed 1 to 50 (of 151 total ) | Next | Last >>
Jump to: